The Library

Circadian gene variants and susceptibility to type 2 diabetes : a pilot study

Tools

Kelly, M. Ann , Rees, Simon D., Hydrie, M. Zafar I., Shera, A. Samad, Bellary, Srikanth, O'Hare, J. Paul, Kumar, Sudhesh, Taheri, S., Basit, Abdul and Barnett, Anthony H.. (2012) Circadian gene variants and susceptibility to type 2 diabetes : a pilot study. PLoS ONE, Vol.7 (No.4). e32670. ISSN 1932-6203

Preview

PDF
jWRAP_Kumar_ournal.pone.0032670.pdf - Published Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (343Kb)

Official URL: http://dx.doi.org/10.1371/journal.pone.0032670

Abstract

Background
Disruption of endogenous circadian rhythms has been shown to increase the risk of developing type 2 diabetes, suggesting that circadian genes might play a role in determining disease susceptibility. We present the results of a pilot study investigating the association between type 2 diabetes and selected single nucleotide polymorphisms (SNPs) in/near nine circadian genes. The variants were chosen based on their previously reported association with prostate cancer, a disease that has been suggested to have a genetic link with type 2 diabetes through a number of shared inherited risk determinants.

Methodology/Principal Findings
The pilot study was performed using two genetically homogeneous Punjabi cohorts, one resident in the United Kingdom and one indigenous to Pakistan. Subjects with (N = 1732) and without (N = 1780) type 2 diabetes were genotyped for thirteen circadian variants using a competitive allele-specific polymerase chain reaction method. Associations between the SNPs and type 2 diabetes were investigated using logistic regression. The results were also combined with in silico data from other South Asian datasets (SAT2D consortium) and white European cohorts (DIAGRAM+) using meta-analysis. The rs7602358G allele near PER2 was negatively associated with type 2 diabetes in our Punjabi cohorts (combined odds ratio [OR] = 0.75 [0.66–0.86], p = 3.18×10−5), while the BMAL1 rs11022775T allele was associated with an increased risk of the disease (combined OR = 1.22 [1.07–1.39], p = 0.003). Neither of these associations was replicated in the SAT2D or DIAGRAM+ datasets, however. Meta-analysis of all the cohorts identified disease associations with two variants, rs2292912 in CRY2 and rs12315175 near CRY1, although statistical significance was nominal (combined OR = 1.05 [1.01–1.08], p = 0.008 and OR = 0.95 [0.91–0.99], p = 0.015 respectively).

Conclusions/significance
None of the selected circadian gene variants was associated with type 2 diabetes with study-wide significance after meta-analysis. The nominal association observed with the CRY2 SNP, however, complements previous findings and confirms a role for this locus in disease susceptibility.

Item Type:

Journal Article

Subjects:

Q Science > QH Natural history > QH426 Genetics
R Medicine > RC Internal medicine

Divisions:

Faculty of Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016)
Faculty of Medicine > Warwick Medical School

Library of Congress Subject Headings (LCSH):

Circadian rhythms, Non-insulin-dependent diabetes -- Susceptibility, Non-insulin-dependent diabetes -- Genetic aspects, Panjabis (South Asian people) -- Genetics

Journal or Publication Title:

PLoS ONE

Publisher:

PLOS

ISSN:

1932-6203

Official Date:

2 April 2012

Dates:

Date	Event
2 April 2012	Published

Volume:

Vol.7

Number:

No.4

Page Range:

e32670

Identification Number:

10.1371/journal.pone.0032670

Status:

Peer Reviewed

Publication Status:

Published

Access rights to Published version:

Open Access

Funder:

Diabetes UK, Pfizer Inc., Sanofi Aventis (Firm), Servier Laboratories UK, Merck Sharp & Dohme, Schering-Plough Corporation, Takeda UK (Firm), Roche, Merck Pharma, Daiichi-Sankyo UK, Boehringer Ingelheim Pharmaceuticals, Eli Lilly and Company, Novo Nordisk, Bristol-Meyers Squibb, Solvay Health Care, Assurance Medical Society UK

Grant number:

07/0003512 (DUK)

References:

1. Chaput JP, Despres JP, Bouchard C, Tremblay A (2007) Association of sleep
duration with type 2 diabetes and impaired glucose tolerance. Diabetologia 50:
2298–2304.
2. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, et al.
(2007) Sleep duration as a risk factor for diabetes incidence in a large US sample.
Sleep 30: 1667–1673.
3. Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA (2009) Adverse metabolic
and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci
USA 106: 4453–4458.
4. Karlsson B, Alfredsson L, Knutsson A, Andersson E, Toren K (2005) Total
mortality and cause-specific mortality of Swedish shift- and dayworkers in the
pulp and paper industry in 1952–2001. Scand J Work Environ Health 31:
30–35.
5. Karlsson B, Knutsson A, Lindahl B (2001) Is there an association between shift
work and having a metabolic syndrome? Results from a population based survey
of 27,485 people. Occup Environ Med 58: 747–752.
6. Maury E, Moynihan Ramsey K, Bass J (2010) Circadian rhythms and metabolic
syndrome: from experimental genetics to human disease. Circ Res 106:
447–462.
7. Marcheva B, Moynihan Ramsey K, Buhr ED, Kobayashi Y, Su H, et al. (2010)
Disruption of the Clock components CLOCK and BMAL1 leads to
hypoinsulinaemia and diabetes. Nature 466: 627–631.
8. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009)
Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77–81.
9. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New
genetic loci implicated in fasting glucose homeostasis and their impact on type 2
diabetes risk. Nat Genet 42: 105–119.
10. Below JE, Gamazon ER, Morrison JV, Konkashbaev A, Pluzhnikov A, et al.
(2011) Genome-wide association and meta-analysis in populations from Starr
County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and
enrichment for expression quantitative trait loci in top signals. Diabetologia 54:
2047–2055.
11. Englund A, Kovanen L, Saarikoski ST, Haukka J, Reunanen A, et al. (2009)
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome.
J Circadian Rhythms 7: 5.
12. Woon PY, Kaisaki PJ, Braganca J, Bihoreau MT, Levy JC, et al. (2007) Aryl
hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with
susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA 104:
14412–14417.
14. Garaulet M, Corbalan-Tutau D, Madrid JA, Baraza JC, Parnell LD, et al.
(2010) Period2 variants are associated with abdominal obesity, psychobehavioural
factors, and attrition in the dietary treatment of obesity. J Am Diet
Assoc 110: 917–921.
15. Conlon M, Lightfoot N, Kreiger N (2007) Rotating shift work and risk of
prostate cancer. Epidemiology 18: 182–183.
16. Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the
risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 2056–2062.
17. Stevens VL, Ahn J, Sun J, Jacobs EJ, Moore SC, et al. (2010) HNF1B and JAZF1
genes, diabetes, and prostate cancer risk. Prostate 70: 601–607.
18. Meyer TE, Boerwinkle E, Morrison AC, Volcik KA, Sanderson M, et al. (2010)
Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities
study. Cancer Epidemiol Biomarkers Prev 19: 558–565.
19. Pierce BL, Ahsan H (2010) Genetic susceptibility to type 2 diabetes is associated
with reduced prostate cancer risk. Hum Hered 69: 193–201.
20. Waters KM, Wilkens LR, Monroe KR, Stram DO, Kolonel LN, et al. (2011) No
association of type 2 diabetes risk variants and prostate cancer risk: the
multiethnic cohort and PAGE. Cancer Epidemiol Biomarkers Prev 20:
1979–1981.
21. Kim S-T, Cheng Y, Tsu F-C, Jin T, Kader AK, et al. (2010) Prostate cancer
risk-associated variants reported from genome-wide association studies: metaanalysis
and their contribution to genetic variation. Prostate 70: 1729–1738.
22. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Metaanalysis
of genome-wide association data and large-scale replication identifies
additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638–645.
23. Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, et al. (2009)
Testing the circadian gene hypothesis in prostate cancer: a population-based
case-control study. Cancer Res 69: 9315–9322.
24. Bellary S, O’Hare JP, Raymond NT, Gumber A, Mughal S, et al. (2008)
Enhanced diabetes care to patients of south Asian ethnic origin (the United
Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet
371: 1769–1776.
25. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:
539–553.
26. Rees SD, Hydrie MZI, Shera AS, Kumar S, O’Hare JP, et al. (2011) Replication
of thirteen GWA-validated risk variants for type 2 diabetes in Pakistani
populations. Diabetologia 54: 1368–1374.
27. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve
type 2 diabetes susceptibility loci identified through large-scale association
analysis. Nat Genet 42: 579–589.
28. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, et al. (2011) Genome-wide
association study in people of South Asian ancestry identifies six novel
susceptibility loci for type 2 diabetes. Nat Genet 43: 984–989.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
30. Zhang EE, Liu Y, Dentin R, Pongsawakul PY, Liu AC, et al. (2010)
Cryptochrome mediates circadian regulation of cAMP signalling and hepatic
gluconeogenesis. Nat Med 16: 1152–1156.
31. Okano S, Hayasaka K, Igarashi M, Iwai H, Togashi Y, et al. (2010) Non-obese
early onset diabetes mellitus in mutant cryptochrome1 transgenic mice. Eur J Clin
Invest 40: 1011–1017.